Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles

被引：0
|
作者：
Tseng, Jill H. [1 ,2 ]
Bristow, Robert E. [1 ]
机构：
[1] Univ Calif Orange, Irvine Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Orange, CA USA
[2] Univ Calif Orange, Irvine Med Ctr, Div Gynecol Oncol, Depart ment Obstet & Gynecol, 333 City Blvd West,Suite 1400, Orange, CA 92868 USA
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷 / 01期
关键词：
NEOADJUVANT CHEMOTHERAPY; SURVIVAL; CARE; CARCINOMA;
D O I：
10.1016/j.ygyno.2022.06.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [21] SURGICAL OUTCOMES OF CYTOREDUCTIVE SURGERY IN METASTATIC AND RECURRENT OVARIAN CANCER
    Gan, C.
    Chiang, P. W.
    Gajjar, K.
    Banks, A.
    Davies, M.
    Wiliamson, K.
    Nunns, D.
    Mohiuddin, K.
    Bharathan, B.
    Irving, G.
    Navarro, A.
    Gomez, D.
    Abu, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 688 - 688
  • [22] Minimally invasive interval cytoreductive surgery for advanced ovarian cancer
    Melamed, Alexander
    Eisenhauer, Eric L.
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (01) : 126 - 127
  • [23] A statement for extensive primary cytoreductive surgery in advanced ovarian cancer
    Nevin, J.
    Luesley, D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (12) : 1586 - 1586
  • [24] Towards a new standard in cytoreductive surgery for advanced ovarian cancer
    Querleu, D.
    Gladieff, L.
    Ferron, G.
    Rouge, P.
    BULLETIN DU CANCER, 2009, 96 (12) : 1175 - 1182
  • [25] The place of secondary complete cytoreductive surgery in advanced ovarian cancer
    Jennifer, Asmar
    Iptissem, Naoura
    Aurelie, Revaux
    Philippe, Kadhel
    Marc, Ayoubi Jean
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2020, 41 (03)
  • [26] Peak postoperative glucose levels predict complications after primary cytoreductive surgery for advanced ovarian cancer
    Axtell, A. E.
    Berry, E.
    Schink, J.
    Holschneider, C. H.
    Walsh, C.
    Cass, I.
    Karlan, B. Y.
    Li, A. J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S40 - S40
  • [27] A statement for extensive primary cytoreductive surgery in advanced ovarian cancer
    Pomel, C.
    Barton, D. P. J.
    McNeish, I.
    Shepherd, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (07) : 808 - 810
  • [28] Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer A Review
    Ibeanu, Okechukwu A.
    Bristow, Robert E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S1 - S11
  • [29] RADICAL CYTOREDUCTIVE SURGERY OF THE UPPER ABDOMEN FOR ADVANCED OVARIAN CANCER
    Kahn, Ryan
    Chi, Dennis
    Broach, Vance
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A246 - A246
  • [30] Peak postoperative glucose levels predict complications after primary cytoreductive surgery for advanced ovarian cancer
    Axtell, A. E.
    Holschneider, C. H.
    Cass, I.
    Walsh, C. S.
    Leuchter, R. S.
    Karlan, B. Y.
    Li, A. J.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 378 - 378
12345